Salas E - Search Results

1

Plasma and peritoneal fluid population pharmacokinetics of micafungin in post-surgical patients with severe peritonitis.

Grau S, Luque S, Campillo N, Samsó E, Rodríguez U, García-Bernedo CA, Salas E, Sharma R, Hope WW, Roberts JA. Grau S, et al. Among authors: salas e. J Antimicrob Chemother. 2015 Oct;70(10):2854-61. doi: 10.1093/jac/dkv173. Epub 2015 Jul 14. J Antimicrob Chemother. 2015. PMID: 26180134

2

Urinary Concentrations of Colistimethate and Formed Colistin after Intravenous Administration in Patients with Multidrug-Resistant Gram-Negative Bacterial Infections.

Luque S, Escaño C, Sorli L, Li J, Campillo N, Horcajada JP, Salas E, Grau S. Luque S, et al. Among authors: salas e. Antimicrob Agents Chemother. 2017 Jul 25;61(8):e02595-16. doi: 10.1128/AAC.02595-16. Print 2017 Aug. Antimicrob Agents Chemother. 2017. PMID: 28559275 Free PMC article.

3

[Shedding light on the use of colistin: still gaps to be filled].

Luque S, Grau S, Berenguer N, Horcajada JP, Sorlí L, Montero MM, Salas E. Luque S, et al. Among authors: salas e. Enferm Infecc Microbiol Clin. 2011 Apr;29(4):287-96. doi: 10.1016/j.eimc.2011.02.003. Enferm Infecc Microbiol Clin. 2011. PMID: 21440335 Review. Spanish.

4

Factors associated with adherence to guidelines for the use of tigecycline in a tertiary care hospital.

Grau S, Conde-Estévez D, Luque S, Alvarez-Lerma F, Horcajada JP, Mateu-De Antonio J, Berenguer N, Salas E. Grau S, et al. Among authors: salas e. J Chemother. 2010 Oct;22(5):339-44. doi: 10.1179/joc.2010.22.5.339. J Chemother. 2010. PMID: 21123158

5

[Mortality risk factors for bloodstream infections caused by extended-spectrum beta-lactamase-producing microorganisms].

Ferrández O, Grau S, Saballs P, Luque S, Terradas R, Salas E. Ferrández O, et al. Among authors: salas e. Rev Clin Esp. 2011 Mar;211(3):119-26. doi: 10.1016/j.rce.2010.05.027. Epub 2011 Mar 2. Rev Clin Esp. 2011. PMID: 21371702 Spanish.

6

Community-acquired pneumonia caused by methicillin-resistant Staphylococcus aureus in critically-ill patients: systematic review.

Carballo N, De Antonio-Cuscó M, Echeverría-Esnal D, Luque S, Salas E, Grau S. Carballo N, et al. Among authors: salas e. Farm Hosp. 2017 Mar 1;41(2):187-203. doi: 10.7399/fh.2017.41.2.10591. Farm Hosp. 2017. PMID: 28236797 Review. English.

7

[Influence of ethnicity on the pharmacokinetics of amikacin].

Barrantes-González M, Grau S, Conde-Estévez D, Salas E, Marín-Casino M. Barrantes-González M, et al. Among authors: salas e. Rev Esp Quimioter. 2013 Dec;26(4):346-52. Rev Esp Quimioter. 2013. PMID: 24399348 Free article. Spanish.

8

Design of a score to identify hospitalized patients at risk of drug-related problems.

Urbina O, Ferrández O, Grau S, Luque S, Mojal S, Marin-Casino M, Mateu-de-Antonio J, Carmona A, Conde-Estévez D, Espona M, González E, Riu M, Salas E. Urbina O, et al. Among authors: salas e. Pharmacoepidemiol Drug Saf. 2014 Sep;23(9):923-32. doi: 10.1002/pds.3634. Epub 2014 May 10. Pharmacoepidemiol Drug Saf. 2014. PMID: 24817497

9

Patient risk factors for developing a drug-related problem in a cardiology ward.

Urbina O, Ferrández O, Luque S, Grau S, Mojal S, Pellicer R, Riu M, Salas E, Comin-Colet J. Urbina O, et al. Among authors: salas e. Ther Clin Risk Manag. 2014 Dec 17;11:9-15. doi: 10.2147/TCRM.S71749. eCollection 2015. Ther Clin Risk Manag. 2014. PMID: 25565852 Free PMC article.

10

Validation of a score to identify inpatients at risk of a drug-related problem during a 4-year period.

Ferrández O, Grau S, Urbina O, Mojal S, Riu M, Salas E. Ferrández O, et al. Among authors: salas e. Saudi Pharm J. 2018 Jul;26(5):703-708. doi: 10.1016/j.jsps.2018.02.020. Epub 2018 Feb 8. Saudi Pharm J. 2018. PMID: 29991914 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

491 results

Search Page